Fig. 11From: Identification of a five-miRNA signature as a novel potential prognostic biomarker in patients with nasopharyngeal carcinomaPrediction of immunotherapy by risk modeling of target genes. A: KM curve of target gene prognostic model in the Imvigor210 dataset. B: ROC curves of the target gene prognostic model in dataset Imvigor210. C: Comparison of immune cell scores between high-risk and low-risk groups in the Imvigor210 dataset. D: Comparison of immune cell scores between high-risk and low-risk groups in the Imvigor210 dataset. E: Comparison of StromalScore, ImmuneScore and ESTIMATEScore between high-risk and low-risk groups in the Imvigor210 dataset. F: Comparison of PDCD1, CTLA4 and IFNG expression between high-risk and low-risk groups in the Imvigor210 dataset. G: Correlation analysis between immune genes and immune cells in the Imvigor210 datasetBack to article page